Brain HealthTau Marker Linked to Alzheimer's Appears Across Several Brain Diseases
A chemical change in the tau protein, called pT217, is widely studied as a marker of Alzheimer's disease. Researchers tested an antibody that recognizes this change in genetically modified mice and human brain tissue collected after death. The human samples included Alzheimer's disease and three other disorders involving abnormal tau buildup. The antibody detected several kinds of tau deposits, performing similarly to an established laboratory marker and similarly to, or slightly better than, a commercial pT217 antibody. These findings suggest pT217 appears across multiple brain diseases and could help researchers examine their underlying damage. They do not show whether blood tests can distinguish these conditions or whether targeting pT217 improves health. This summary is based on the abstract only, which does not provide sample sizes or detailed statistical results.
